Print

Cancer Drug Prevents Build-Up of Toxic Brain Protein, Georgetown University Medical Center Study  
5/10/2013 7:52:58 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published online May 10 in Human Molecular Genetics, offers a unique and exciting strategy to treat neurodegenerative diseases that feature abnormal buildup of proteins in Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, Huntington disease and Lewy body dementia, among others.


//-->